home / stock / prnb / prnb news


PRNB News and Press, Principia Biopharma Inc. From 08/17/20

Stock Information

Company Name: Principia Biopharma Inc.
Stock Symbol: PRNB
Market: NASDAQ
Website: principiabio.com

Menu

PRNB PRNB Quote PRNB Short PRNB News PRNB Articles PRNB Message Board
Get PRNB Alerts

News, Short Squeeze, Breakout and More Instantly...

PRNB - Principia Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Principia Biopharma Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - PRNB

NEW YORK, NY / ACCESSWIRE / August 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Principia Biopharma Inc. (NASDAQ:PRNB) to Sanofi for $100 per share in cash is fair to Principia shareholders. On behalf of Principia shareholders, Halper S...

PRNB - Merger Arbitrage Mondays - Qiagen Shareholders Want More

Merger activity increased significantly last week with eight new deals announced and one deal terminated. This is the highest number of deals announced in a single week this year but most of these deals were relatively small compared to the multi-billion-dollar deals we saw in the week prior...

PRNB - Sanofi to acquire Principia Biopharma

PARIS and SOUTH SAN FRANCISCO, Calif. , Aug. 17, 2020 /PRNewswire/ -- Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acq...

PRNB - Principia Biopharma EPS beats by $1.36, beats on revenue

Principia Biopharma (NASDAQ: PRNB ) : Q2 GAAP EPS of $0.31 beats by $1.36 . More news on: Principia Biopharma Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

PRNB - Principia Biopharma Reports Second Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated diseases, today announced financial results for the second quarter ended June 30, 2020. ...

PRNB - A biopharma with 54% upside, with or without M&A - Evercore

Chatter about a potential buyout has lifted the stock of immune-disorder therapy developer Principia Biopharma (NASDAQ: PRNB ) - shares are up 13.6% since Sanofi (NASDAQ: SNY ) was linked to interest, and they're up 49% over the past three weeks - but a takeover isn't even part of ...

PRNB - Biotech Bonanza - Second Half Outlook

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...

PRNB - Stocks To Watch: Vaccine Players, Earnings Blitz And Fiscal Debate

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

PRNB - Principia Sanofi Rumors, And Other News: The Good, Bad And Ugly Of Biopharma

Principia Biopharma Perks Up on Sanofi Rumors Principia Biopharma (PRNB) shot up due to swirling rumors regarding Sanofi's (SNY) interest in the firm. The French pharma company is currently looking to expand its presence in the United States and is weighing different options. Principia is ...

PRNB - HTBX, DGLY, CLNY and RYCE among midday movers

Gainers:  InnerWorkings (NASDAQ: INWK ) +117% . More news on: InnerWorkings, Inc., Heat Biologics, Inc., Boxlight Corporation, Stocks on the move, , Read more ...

Previous 10 Next 10